financial estimates
Castle Biosciences Estimates 2022 Revenues in Line With Prior Projections
The company said it expects full-year revenues of at least $132 million to $137 million, with test volumes up significantly across the majority of its menu.
Exact Sciences Projects 28 Percent Bump in Total Q4 Oncology Revenue
The company expects to report consistent growth in both cancer screening and precision oncology testing for the quarter and the full fiscal year.
Sema4 Changes Name to GeneDx, Provides Preliminary 2022 Revenues, 2023 Guidance
As it exits reproductive health screening this quarter, the newly renamed GeneDx expects 2022 revenues of $170 million to $173 million and 2023 revenues of $205 million to $220 million in pursuit of profitability by 2025.
Agilent Fiscal Q4 Revenues Rise 11 Percent, Full-Year 2022 Revenues Grow 8 Percent
The firm's Life Sciences and Applied Markets group's revenues were up 16 percent, and the Diagnostics and Genomics group's revenues grew 3 percent.
Invitae to Lay Off Over 1,000 Workers Amid Restructuring, Leadership Transition
The company plans to eliminate non-core operations and focus on core business lines that generate sustainable revenue.